• Unlocking the Future of Presbyopia Drop Treatment with LNZ100

  • 2024/12/09
  • 再生時間： 37 分
  • ポッドキャスト

Unlocking the Future of Presbyopia Drop Treatment with LNZ100

無料で聴く

ポッドキャストの詳細を見る

  • サマリー

  • LNZ100 represents a new generation of miotic eye drops, which, unlike its predecessors, is not based on pilocarpine. Instead, it uses aceclidine, a unique muscarinic agonist selective for the iris’s smooth muscle, facilitating pupil constriction with negligible influence on the ciliary muscle. This distinction is essential to achieve a smaller pinhole pupil without a myopic shift.
    続きを読む 一部表示

あらすじ・解説

LNZ100 represents a new generation of miotic eye drops, which, unlike its predecessors, is not based on pilocarpine. Instead, it uses aceclidine, a unique muscarinic agonist selective for the iris’s smooth muscle, facilitating pupil constriction with negligible influence on the ciliary muscle. This distinction is essential to achieve a smaller pinhole pupil without a myopic shift.
続きを読む 一部表示

Unlocking the Future of Presbyopia Drop Treatment with LNZ100に寄せられたリスナーの声

カスタマーレビュー：以下のタブを選択することで、他のサイトのレビューをご覧になれます。

Audible.co.jp

Amazon.co.jp
レビューはまだありません。